The utility of EMG interference pattern analysis in botulinum toxin treatment of torticollis: A randomised, controlled and blinded study

Clinical Neurophysiology

Volumn 122, Issue 11, 2011, Pages 2305-2309

  Werdelin, L ^a   Dalager, T ^b   Fuglsang Frederiksen, A ^c   Regeur, L ^a   Karlsborg, M ^a   Korbo, L ^a   Munck, O ^a   Winge, K ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Botulinum toxin; Dystonia; Quantitative EMG; Torticollis; Treatment

Indexed keywords

BOTULINUM TOXIN A; PROMETHAZINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; ELECTROMYOGRAM; FEMALE; HUMAN; MALE; NECK MUSCLE; PATTERN RECOGNITION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STERNOCLEIDOMASTOID MUSCLE; TORTICOLLIS; TREATMENT OUTCOME;

ADULT; AGED; BOTULINUM TOXINS, TYPE A; ELECTROMYOGRAPHY; EVOKED POTENTIALS, MOTOR; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; NECK MUSCLES; NEUROMUSCULAR AGENTS; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TORTICOLLIS; TREATMENT OUTCOME;

EID: 80053210365     PISSN: 13882457     EISSN: 18728952     Source Type: Journal    
DOI: 10.1016/j.clinph.2011.04.012     Document Type: Article

References (22)

1. Brans J.W., Aramideh M., Koelman J.H., Lindeboom R., Speelman J.D., de Ongerboer V. Electromyography in cervical dystonia: changes after botulinum and trihexyphenidyl. Neurology 1998, 51:815-819.
2. Brans J.W., de Boer I., Aramideh M., de Ongerboer V., Speelman J.D. Botulinum toxin in cervical dystonia: low dosage with electromyographic guidance. J Neurol 1995, 242:529-534.
3. Buchman A.S., Comella C.L., Stebbins G.T., Tanner C.M., Goetz C.G. Quantitative electromyographic analysis of changes in muscle activity following botulinum toxin therapy for cervical dystonia. Clin Neuropharmacol 1993, 16:205-210.
4. Comella C.L., Buchman A.S., Tanner C.M., Brown-Toms N.C., Goetz C.G. Botulinum toxin injection for spasmodic torticollis: increased magnitude of benefit with electromyographic assistance. Neurology 1992, 42:878-882.
5. Comella C.L., Pullman S.L. Botulinum toxins in neurological disease. Muscle Nerve 2004, 29:628-644.
6. Dauer W.T., Burke R.E., Greene P., Fahn S. Current concepts on the clinical features, aetiology and management of idiopathic cervical dystonia. Brain 1998, 121:547-560.
7. Dressler D. Electromyographic evaluation of cervical dystonia for planning of botulinum toxin therapy. Eur J Neurol 2000, 7:713-718.
8. Erdal J., Ostergaard L., Fuglsang-Frederiksen A., Werdelin L., Dalager T., Sjo O., et al. Long-term botulinum toxin treatment of cervical dystonia-EMG changes in injected and noninjected muscles. Clin Neurophysiol 1999, 110:1650-1654.
9. Fahn S., Marsden C.D., Calne D.B. Classification and investigation of dystonia. Movement Disorders 2 1987, 322-358. Butterworths, London. C.D. Marsden, S. Fahn (Eds.).
10. Finsterer J., Fuchs I., Mamoli B. Quantitative electromyography-guided botulinum toxin treatment of cervical dystonia. Clin Neuropharmacol 1997, 20:42-48.
11. Fuglsang-Frederiksen A., Ostergaard L., Sjo O., Werdelin L., Winkel H. Quantitative electromyographical changes in cervical dystonia after treatment with botulinum toxin. Electromyogr Clin Neurophysiol 1998, 38:75-79.
12. Fuglsang-Frederiksen A., Sjo O., Winkel H. Quantitative electromyography as a guidance for botulinum toxin treatment in torticollis patients. Muscle Nerve 1991, 14:895.
13. Jankovic J., Brin M.F. Therapeutic uses of botulinum toxin. N Engl J Med 1991, 324:1186-1194.
14. Jankovic J., Schwartz K. Botulinum toxin injections for cervical dystonia. Neurology 1990, 40:277-280.
15. Marsden C.D., Quinn N.P. The dystonias. BMJ 1990, 300:139-144.
16. Østergaard L., Fuglsang-Frederiksen A., Sjo O., Werdelin L., Winkel H. Quantitative EMG in cervical dystonia. Electromyogr Clin Neurophysiol 1996, 36:179-185.
17. Østergaard L., Fuglsang-Frederiksen A., Werdelin L., Sjo O., Winkel H. Quantitative EMG in botulinum toxin treatment of cervical dystonia. A double-blind, placebo-controlled study. Electroencephalogr Clin Neurophysiol 1994, 93:434-439.
18. Singer C., Shulman L., Parra A., Weiner W. Analysis of variables affecting botulinum toxin response in spasmodic torticollis. Ann Neurol 1994, 36:317.
19. Skogseid I.M., Kerty E. The course of cervical dystonia and patient satisfaction with long-term botulinum toxin A treatment. Eur J Neurol 2005, 12:163-170.
20. Speelman J.D., Brans J.W. Cervical dystonia and botulinum treatment: is electromyographic guidance necessary?. Mov Disord 1995, 10:802.
21. Tarsy D. Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin. Mov Disord 1997, 12:100-102.
22. Van Gerpen J.A., Matsumoto J.Y., Ahlskog J.E., Maraganore D.M., McManis P.G. Utility of an EMG mapping study in treating cervical dystonia. Muscle Nerve 2000, 23:1752-1756.